Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3% Diquafosol in Diabetic Dry Eye
NCT05193331Unknown
- Sponsor
- He Eye Hospital
- Start
- Apr 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of diquafosol in dry eye disease (DED), sponsored by He Eye Hospital. Primary endpoint: Non-invasive tear break-up time at 8 weeks. Status: unknown.
02
Drugs
diquafosol
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05193331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05193331.